Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.
Frequently asked questions
What sector does Medartis Holding AG (MED) operate in?
Medartis Holding AG belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Medartis Holding AG (MED) current stock price?
As of the latest data, Medartis Holding AG stock price is CHF 86.90, with a previous close of CHF 86.90.
What is Medartis Holding AG (MED) current market capitalization?
Medartis Holding AG market cap is approximately 1.08 billion.
What is Medartis Holding AG (MED) Earnings Per Share (EPS)?
The trailing EPS is CHF 0.67, and the forward EPS is CHF 2.24.
What is Medartis Holding AG (MED) Price-to-Earnings (P/E) ratio?
Medartis Holding AG current P/E ratio is 129.7, with a forward P/E of 38.83.
Does Medartis Holding AG (MED) pay dividends?
No. Medartis Holding AG does not pay a dividend.
When is Medartis Holding AG (MED) next earnings report?
Medartis Holding AG is expected to release its next earnings report on June 30, 2026.
What is Medartis Holding AG (MED) beta (volatility) score?
Medartis Holding AG has a beta of 1.170, meaning its volatility is roughly in line with the market.
